Martin Shkreli isn't the only one who tries to stay out of trouble.
The notorious "pharma bro," who rose to prominence for jacking the price of a life-saving medication sky high, has been involved in two new investigations just months after getting out of prison
The Daily Beast reported Tuesday that Shkreli's new business, Druglike, is drawing the attention of authorities.
The launch of Druglike, despite being banned from the medical industry forever, was announced on Monday, one day before the attorneys general started looking into Shkreli's case.
This was only after Shkreli made a joke about his prison cell being filled with Kitkats.
Druglike was founded because traditional drug discovery software is too difficult and expensive to use. The communities that are most in need of access to these tools are those focused on rare diseases.
The jury is out on whether one of the world's sleaziest hedge fund managers can actually deliver on his promises.
The attorneys general don't know what they're looking into. As of this writing, neither the New York or North Carolina attorney generals have issued press releases with additional information regarding their investigations.
The Daily Beast reported that Stein's office was concerned about the development and would be looking into it.
Maybe Shkreli has changed his mind. If he's back on the same shit, he might want to look at what the supply chain looks like in the future.
A study suggests that a pill can reduce the risk of hereditary cancer.
All Rights Reserved © 2024
